Cortisol levels and responses to mammography screening in breast cancer survivors: A pilot study

Psychosomatic Medicine

Volumn 65, Issue 5, 2003, Pages 842-848

  Porter, Laura S ^a,b   Mishel, Merle ^a   Neelon, Virginia ^a   Belyea, Michael ^a   Pisano, Etta ^a   Soo, Mary Scott ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Cancer survivorship; Cortisol; Stress

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAMMOGRAPHY; MOOD; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SALIVA LEVEL; STRESS;

EID: 0141634213     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000088595.91705.C5     Document Type: Article

References (50)

1. Ferrell BR, Grant MM, Funk BM, Otis-Green SA, Garcia NJ. Quality of life in breast cancer survivors: Implications for developing support services. Oncol Nurs Forum 1998;25:887-95.
2. Fredett SL. Breast cancer survivors: Concerns and coping. Cancer Nurs 1995;18:35-46.
3. Muzzin LJ, Anderson NJ, Figuerdo AT, Gudelis SO. The experience of cancer. Soc Sci Med 1994;38:1201-1208.
4. Meyer L, Aspegren K. Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer. Acta Oncol 1989;28:13-8.
5. Halttunen A, Hietanen P, Jallinoja P, Lonnqvist J. Getting free of breast cancer: An eight-year perspective of the relapse-free patients. Acta Oncol 1992;31:307-10.
6. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Res Treat 1996;38:183-99.
7. Paci E, Cariddi A, Barchielli A, et al. Long-term sequelae of breast cancer surgery. Tumori 1996;82:321-4.
8. Mishel MH. Managing uncertainty in older breast cancer survivors. Unpublished, 1998.
9. Polinsky ML. Functional status of long-term breast cancer survivors: Demonstrating chronicity. Health Soc Work 1994;19:165-73.
10. Vickburg SMJ. The possibility of breast cancer recurrence: Coping with perceived threats. Ann Behav Med 2000;22:S044.
11. Deleted in proof.
12. Deleted in proof.
13. Deleted in proof.
14. Cordova MJ, Andrykowski MA, Kenady DE, McGrath PC, Sloan DA, Redd WH. Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol 1995;63:981-6.
15. Pelusi J. The lived experience of surviving breast cancer. Oncol Nurs Forum 1997;24:1343-53.
16. Steggles S, Lightfoot N, Sellick SM. Psychological distress associated with organized breast cancer screening. Cancer Prev Control 1998;2:213-20.
17. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol 1994;49:389-404.
18. Heim C, Ehlert U, Helhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000;25:1-35.
19. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-9.
20. Mason JW. A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med 1968;1968:30:567-60.
21. Rose RM. Overview of endocrinology of stress. In: Brown GM, Koslow SH, Reichlin S, editors. Neuroendocrinology and Psychiatric Disorders. New York: Raven Press; 1984. p. 95-122.
22. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research: An overview. Neuropsychobiology 1989;22:150-69.
23. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 1994;19:313-33.
24. Hays JH, O'Brian JT. Endocrine and metabolic function in patients with neoplastic disease. In: Herberman RB, editor. Influence of the Host of Tumor Development. Dordrecht: Kluwer Academic Publishers; 1989. p. 530-43.
25. Van de Pompe G, Antoni MH, Heijnen CJ. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996;21:361-74.
26. Giese-Davis J, Sephton S, Spiegel D. Repression associated with a physiological risk factor for shorter survival in women with metastatic breast cancer. Annals Behav Med 2000;22:S054.
27. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of mortality in metastatic breast cancer patients. J Natl Canccer Inst 2000;92:994-1000.
28. Pruessner JC, Wolf OT, Hellhammer DH, et al. Free cortisol levels after awakening: A reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997;26:2539-49.
29. Deleted in proof.
30. Deleted in proof.
31. Deleted in proof.
32. Zakowski SG, Valdimarsdottir HB, Bovberg DH, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 1998;19:362-9.
33. Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 1997;59:459-66.
34. Diener E, Emmons R. The independence of positive and negative affect. J Pers Soc Psychol 1985;47:1105-17.
35. Emmons R, Diener E. Personality correlates of subjective well-being. Pers Soc Psychol Bull 1984;11:89-97.
36. Smyth J, Ockenfels M, Porter LS, Kirschbaum C, Hellhammer D, Stone A. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology 1998;23:353-70.
37. Stone AA, Broderick JE, Porter LS, Kaell AT. The experience of rheumatoid arthritis pain and fatigue: Examining momentary reports and correlates over one week. Arthritis Care Res 1997;10:185-93.
38. Stone AA, Neale JM. New measure of daily coping: Development and preliminary results. J Pers Soc Psychol 1984;46:892-906.
39. Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: A questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 1992;34:1129-34.
40. Schwartz JE, Stone AA. Strategies for analyzing ecological momentary assessment data. Health Psychol 1998;17:6-16.
41. Turner-Cobb J, Sephton S, Koopman C, Blake-Mortimer J, Spiegel D. Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med 2000;62:337-45.
42. Smyth JS, Ockenfels MC, Gorin AA, et al. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 1997;22:89-105.
43. Schommer NC, Kudielka BM, Hellhammer DH, Kirchbaum C. No evidence for a close relationship between personality traits and circadian cortisol rhythm or a single cortisol stress response. Psychol Rep 1999;84:840-2.
44. Cruess DG, Antoni M, McGregor BA, et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med 2000;62:304-8.
45. Munck A, Guyre P. Glucocorticoids and immune function. In: Ader R, Feten D, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 1991. P. 447-74.
46. Matthews KA, Gump BB, Owens JF. Chronic stress influences cardiovascular and neuroendocrine responses during acute stress and recovery, especially in men. Health Psychol 2001;20:403-10.
47. Gump BB, Matthews KA. Do background stressors influence reactivity to and recovery from acute stressors? J Appl Soc Psychol 1999;29:469-94.
48. Vinokur AD, Threatt BA, Caplan RD, Zimmerman BL. Physical and psychosocial functioning and adjustment to breast cancer: Long-term follow-up of a screening population. Cancer 1989;63:394-405.
49. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: Comparison on 8-year survivors with population controls. J Clin Oncol 1998;16:487-94.
50. Epel ES, McEwen B, Seeman T, et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med 2000;62:623-3.